| abstract |
UNPREDITED PEPTIDE FOR TREATMENT AND PREVENTION OF DISORDERS RELATED TO THE IMMUNOLOGICAL SYSTEM, INCLUDING TREATMENT AND PREVENTION OF INFECTION BY MODULATION OF INNACTED IMMUNITY. In one aspect, the present invention provides novel isolated peptides that can be used to modulate innate immunity in an individual and / or for the treatment of an immune system disorder, including the treatment and prevention of innate immunity modulation infection. . Also provided is a peptide reactive agent, a pharmaceutical composition comprising the peptide, an isolated nucleic acid molecule encoding the peptide, a recombinant nucleic acid construct including the nucleic acid molecule, at least one host cell comprising the construction of recombinant nucleic acid and a method of peptide production using the host cell. The present invention further provides a method for treating and / or preventing infection in an individual by administering the peptide of the invention to the individual, thereby modulating the innate immunity in the individual. Additionally, the present invention provides a method for predicting whether an individual would respond to treatment with a peptide of the invention. |